Signaturefd, LLC Global Blood Therapeutics, Inc. Transaction History

Signaturefd, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$32.4 - $68.18 $583 - $1,227	18 New	18 $1,000
Q1 2021 Apr 30, 2021	SELL	$38.94 - $50.85 $1,518 - $1,983	-39 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$37.65 - $63.77 $37 - $63	-1 Reduced 2.5%	39 $2,000
Q1 2020 Apr 23, 2020	BUY	$41.72 - $87.2 $1,627 - $3,400	39 Added 3900.0%	40 $2,000
Q4 2019 Feb 05, 2020	BUY	$45.7 - $81.86 $45 - $81	1 New	1 $0
Q3 2019 Oct 16, 2019	SELL	$45.35 - $57.91 $45 - $57	-1 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$52.6 - $63.29 $52 - $63	1 New	1 $0
Q4 2018 Feb 13, 2019	SELL	$31.54 - $46.67 $63 - $93	-2 Closed	0 $0
Q1 2018 May 08, 2018	BUY	$39.6 - $65.9 $79 - $131	2 New	2 $0

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.